Ewing Sarcoma Therapeutics, Clinical Trials, Results, Patent, Designation, Collaboration & Pipeline Analysis

By -
Ewing sarcoma pipeline comprises approximately 29 drug candidates in different stages of development. Ewing sarcoma is a condition in which formation of cancer or tumor takes place in bones and soft tissues. The symptoms associated with Ewing sarcoma include pain as well as swelling in the chest, back, legs, pelvis and arms, lumps in arms, bone fracture, weight loss, loss of appetite, fatigue, malaise, etc.
The pipeline for Ewing sarcoma was analyzed based on the route of administration and it was found that most of the drug candidates are being developed to be administered by oral route.
Download Sample of This Research Report:  https://www.psmarketresearch.com/market-analysis/ewing-sarcoma-therapeutics-pipeline-analysis/report-sample



The research also found that various companies are engaged in collaborations for Ewing sarcoma. In April 2014, NanoSmart Pharmaceuticals Inc. and NanoValent Pharmaceuticals Inc., entered into a research collaboration agreement to find out the feasibility of jointly developing an ANA-conjugated liposomal doxorubicin nanoparticle for the treatment of ovarian cancer and other solid tumors.

Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=ewing-sarcoma-therapeutics-pipeline-analysis

Novel technologies are being used for Ewing sarcoma drug candidates. MacroGenics Inc., has been using Fc Optimization platform for the development of their drug candidates.
Some of the key players developing Ewing sarcoma therapeutics include Celgene Corporation, Pfizer Inc., and Novartis AG, and others.
Ewing sarcoma Pipeline Analysis
·         By Phase
·         By Route of Administration
·         By Molecule Type
·         By Company


Contact:
Mr. Kundan Kumar
Manager – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +18887787886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook

Comments

Post a Comment

Popular posts from this blog

How is Increasing Focus on Personalized Medicine Driving Cancer/Tumor Profiling Market?

By -
Image
Every year, over 9.5 million people die as result of cancer, as per the World Health Organization (WHO), thereby becoming one of the major reasons for human mortality around the world. The disease, which is most prominently characterized by the presence of tumors, forms when a mutation (undesirable change) in a gene or protein causes a particular type of cell to divide faster than the rate of the normal cell death, thereby resulting in the growth of a visible mass.  Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/cancer-profiling-market/report-sample This is concurrent with the fact that among the genomics, proteomics, metabolomics, and epigenetics techniques, genomics is the most widely used one. As the root cause of the cancer can be determined by studying which gene mutated and how, targeted therapies can be devised. Such analysis can also help ascertain if the patient would be at risk of a relapse. All these techniques and technologies find ...
Read more

What are Major Factors Driving Progress of Global Next-Generation Antibody Therapeutics Market?

By -
Image
 The increasing number of technological developments in the healthcare industry is one of the major factors fuelling the surge in the demand for next-generation antibody therapeutics solutions throughout the globe. For instance, there have been major developments in the healthcare technologies over the last few years such as the development of bispecific antibodies (BsAbs), ADC technologies, and glycoengineered antibody. These advancements have significantly increased the application area of the antibody therapeutics. The other major factor propelling the demand for next-generation antibody therapeutics solutions is the increasing prevalence of chronic diseases across the world. Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/next-generation-antibody-market/report-sample ADCs are widely considered to be much safer and effective than the conventionally used antibodies for cancer treatment as these are made by combining a biologically active cytot...
Read more

How is Popularity of Personalize Medicine Helping Oligonucleotide Synthesis Market Advance?

By -
Image
Though there are a set number of health conditions that can affect people, the actual effect they have can vary from one individual to another. This is because, though similar, every human is slightly different on the genetic level. Consequently, one treatment that works for one patient has no guarantee of working for another. With the realization of this fact, the medical specialty of personalized medicine has emerged, wherein the genetics of a person are studied to devise a suitable treatment. Receive Sample Copy of this Report: https://www.psmarketresearch.com/market-analysis/oligonucleotide-synthesis-market/report-sample With extensive research and development (R&D), scientists have realized that a lot of diseases are caused by mutations in a particular gene, and if that particular gene is somehow deactivated, the disease could be managed. One of the ways it is being done is by artificially producing an antisense oligonucleotide, which is a single-strand deoxyribonucleic a...
Read more